🔎 Trials Near Me

Inicio › Obesidad › Georgia

Ensayos clínicos de Obesidad en Georgia

46 estudios sobre Obesidad buscan participantes en Georgia.

Ciudades en Georgia

Texto oficial del estudio (inglés)

Home Self-administration of Maridebart Cafraglutide With Autoinjector in Adults Living With Obesity or Overweight

  • Nsc Research, Johns Creek
  • North Georgia Clinical Research, Woodstock
ReclutandoFase 3
Edades de 18 a 99 · Todos los sexos · Actualizado el 9 nov 2026 · NCT07871409

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

  • Rophe Adult and Pediatric Medicine/SKYCRNG, Union City
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 9 nov 2026 · NCT07351045

A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus

  • Research Site, Stockbridge
  • Research Site, Woodstock
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 9 nov 2026 · NCT07776509

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

  • Centricity Research Columbus Georgia Multispecialty, Columbus
  • Atlanta Veterans Affairs Medical Center, Decatur
  • Rophe Adult and Pediatric Medicine/SKYCRNG, Union City
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 9 nov 2026 · NCT07351058

Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)

  • East Coast Institute for Research, Canton
  • Nsc Research, Johns Creek
  • Rophe Adult and Pediatric Medicine/Sky Clinical Research Network Group, Union City
  • y 1 más
ReclutandoFase 3
Edades de 18 a 99 · Todos los sexos · Actualizado el 6 nov 2026 · NCT07575399

A Study to Learn About Study Medicine Called Berobenatide in Adults With Knee Pain and Overweight or Obesity (VESPER-OA 1)

  • Clinical Research Atlanta, Stockbridge
  • North Georgia Clinical Research, LLC, Woodstock
  • North Georgia Internal Medicine, Woodstock
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 5 nov 2026 · NCT07919678

A Study of EloraTZP in Adult Participants With Obesity or Overweight and Type 2 Diabetes

  • Care Access - Dalton - Clinical Trials Center by Walmart & Care Access, Dalton
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT07881458

Efficacy, Safety, and Pharmacokinetics of Tirzepatide (LY3298176) Once Weekly Versus Placebo in Pediatric Participants 6 to Less Than 12 Years of Age Who Have Obesity (ADVANCE-SURMOUNT-KIDS)

  • Children's Healthcare of Atlanta - Center for Advanced Pediatrics, Atlanta
ReclutandoFase 3
Edades de 6 a 11 · Todos los sexos · Actualizado el 4 nov 2026 · NCT07817875

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

  • Teak Research Consults - Dunwoody, Dunwoody
  • Teak Research Consults, Lawrenceville
  • The Jones Center Clinical Research, Macon
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT07282600

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

  • Teak Research Consults - Dunwoody, Dunwoody
  • Center for Advanced Research & Education, Gainesville
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT07392190

Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight

  • Orita Clinical Research, Decatur
  • North Georgia Clinical Research, Woodstock
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT07353931

A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight

  • Teak Research Consults, Lawrenceville
  • EBGS Clinical Research Center, Snellville
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT07369011

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

  • Children's Healthcare of Atlanta - Center for Advanced Pediatrics, Atlanta
ReclutandoFase 3
Edades de 6 a 17 · Todos los sexos · Actualizado el 4 nov 2026 · NCT06672549

A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide

  • Balanced Life Health Care Solutions/SKYCRNG, Lawrenceville
  • Physicians Research Associates, Lawrenceville
  • Rophe Adult and Pediatric Medicine/SKYCRNG, Union City
  • y 1 más
ReclutandoFase 2
Edades de 18 a 75 · Todos los sexos · Actualizado el 4 nov 2026 · NCT06897475

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

  • North Georgia Clinical Research, Woodstock
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 3 nov 2026 · NCT07783802

A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus

  • Research Site, Stockbridge
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 30 oct 2026 · NCT07784725

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

  • Piedmont Heart Institute, Atlanta
  • Privia Medical Group Georgia LLC, Peachtree City
ReclutandoFase 3
Edades de 18 a 99 · Todos los sexos · Actualizado el 29 oct 2026 · NCT07037459

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

  • Research Site, Woodstock
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 28 oct 2026 · NCT07784270

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

  • Endocrine Research Solutions /ID# 282020, Roswell
ReclutandoFase 2
Edades de 18 a 75 · Todos los sexos · Actualizado el 27 oct 2026 · NCT07752979

Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss

  • North Georgia Clinical Research, Woodstock
ReclutandoFase 2
Edades de 18 a 75 · Todos los sexos · Actualizado el 26 oct 2026 · NCT07837973

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

  • ACCOMPLISH-2 Research Site, Atlanta
  • ACCOMPLISH-2 Research Site, Columbus
  • ACCOMPLISH-2 Research Site, Lawrenceville
  • y 2 más
ReclutandoFase 3Se aceptan voluntarios sanos
Edades de 18 a 79 · Todos los sexos · Actualizado el 20 oct 2026 · NCT07654374

Evaluation of the Tolerability of Cagrilintide in Participants Not Tolerating GLP-1-RA Therapies Due to Gastrointestinal Adverse Events

  • Hope Clin Res & Wellness, Conyers
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 19 oct 2026 · NCT07607587

The RESET System Pivotal Clinical Trial (Protocol Revision K)

  • Denali Health Atlanta, Atlanta
  • Drug Studies America, Marietta
  • EBGS Clinical Research, Snellville
Reclutando
Edades de 22 a 65 · Todos los sexos · Actualizado el 13 oct 2026 · NCT04101669

AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea

  • NeuroTrials Research, Inc., Atlanta
  • Physicians Research Associates, Lawrenceville
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 7 oct 2026 · NCT07571109

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

  • Center for Advanced Research and Education, Gainesville
  • Rophe Adult and Pediatric Medicine/Sky Clinical Research Network Group, Union City
ReclutandoFase 3
Edades de 18 a 99 · Todos los sexos · Actualizado el 5 oct 2026 · NCT07684235

A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight

  • Children's Healthcare Atlanta, Atlanta
  • Columbus Research Foundation, Columbus
  • Accel Research Sites-NeuroStudies, Decatur
  • y 1 más
ReclutandoFase 3
Edades de 8 a 18 · Todos los sexos · Actualizado el 30 sept 2026 · NCT07253285

AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight

  • Hope Clin Res & Wellness, Conyers
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 28 sept 2026 · NCT07720271

A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide

  • Conquest Research, Atlanta
  • Eastside Bariatric and Gen Surg, Snellville
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 28 sept 2026 · NCT07668414

AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose Weight

  • Hope Clin Res & Wellness, Conyers
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 24 sept 2026 · NCT07339423

A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes

  • Teak Research Consults - Dunwoody, Dunwoody
  • Teak Research Consults, Lawrenceville
  • Clinical Research Atlanta, Stockbridge
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 22 sept 2026 · NCT07321886

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

  • AURORA-2 Clinical Site, Canton
  • AURORA-2 Clinical Site, Decatur
  • AURORA-2 Clinical Site, Union City
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 16 sept 2026 · NCT07743450

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

  • AURORA-1 Clinical Site, Canton
  • AURORA-1 Clinical Site, Decatur
  • AURORA-1 Clinical Site, Union City
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 16 sept 2026 · NCT07743463

First-in-human Study of the Safety, Tolerability, Pharmacokinetics, and Food Effect of ACCG-2671

  • Research Site, Decatur
ReclutandoFase 1/2Se aceptan voluntarios sanos
Edades de 25 a 75 · Todos los sexos · Actualizado el 14 sept 2026 · NCT07815678

AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea

  • Conquest Research, Atlanta
  • Physicians Research Associates, Lawrenceville
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 11 sept 2026 · NCT07571005

Intermittent Cottonseed Oil Consumption

  • University of Georgia, Athens
ReclutandoSe aceptan voluntarios sanos
Edades de 25 a 75 · Todos los sexos · Actualizado el 9 sept 2026 · NCT07246408

Cottonseed Oil Versus Matched PUFA Effects

  • University of Georgia, Athens
ReclutandoSe aceptan voluntarios sanos
Edades de 25 a 75 · Todos los sexos · Actualizado el 9 sept 2026 · NCT06382298

A Research Study to Compare Two Different Versions of Injectable Cagrilintide and Placebo in People With Excess Body Weight

  • Hope Clin Res & Wellness, Conyers
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 4 sept 2026 · NCT07745504

Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL

  • Children's Healthcare of Atlanta at Egleston, Atlanta
ReclutandoFase 2
Edades de 7 a 25 · Todos los sexos · Actualizado el 19 ago 2026 · NCT05082519

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

  • American Clinical Trials, LLC, Acworth
  • Atlanta Center for Clinical Research_Atlanta, Atlanta
  • East Atlanta Cardiology, Conyers
  • y 6 más
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 18 ago 2026 · NCT07567001

De ClinicalTrials.gov, datos obtenidos el 15 nov 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.